Gingival defects can be treated in multiple ways. The current gold standard is connective tissue graft (CTG) in order to treat Class I and II Miller defects (Chambrone, 2008). One of the newer procedures is the use of platelet-rich fibrin (PRF) therapy, which involves drawing the patient’s own blood and forming a membrane to heal gingival defects. This literature review looks at scholarly articles comparing the use of PRF to CTG in healing clinical attachment loss (CAL) over a period of 6 months and whether one is more effective than the other in gaining CAL.

As the largest elementary school in the city of San Francisco, Gordon J. Lau Elementary School (GJL) presented an ideal opportunity to reach out to many children in the Chinatown neighborhood and provide education, screenings, and fluoride varnish. SCOPE hopes to not only offer these services to the students of GJL on a regular basis but also to expand its outreach to more elementary schools throughout the San Francisco.